コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 portal vein in continuity with the inferior mesenteric vein.
2 genous insulin replacement into the superior mesenteric vein.
3 ough a Hickman line inserted in the inferior mesenteric vein.
4 utflow by a proximal segment of the superior mesenteric vein.
5 tumor, normal pancreas, aorta, and superior mesenteric vein.
6 eric artery and a catheter into the superior mesenteric vein.
7 ent with a stent extending into the superior mesenteric vein.
8 d splenic vein, causing an engorged inferior mesenteric vein.
9 o the confluence of the splenic and superior mesenteric veins.
10 on of the main portal vein, splenic vein, or mesenteric veins.
11 ary tumor (98%), portal vein (97%), superior mesenteric vein (94%), hepatic artery (93%), and superio
13 invasion, and flow artifacts in the superior mesenteric vein and measured attenuation of tumor, norma
18 at the tail of the pancreas and the superior mesenteric vein at the level of the mesentery or head of
20 ts and decreased attenuation in the superior mesenteric vein, compared with the artifacts revealed on
21 ze with abutment of the portal vein-superior mesenteric vein confluence for less than 180 degrees .
22 ely to have a difficult portal vein/superior mesenteric vein dissection when compared to the PA patie
26 inferior mesenteric artery (IMA) or inferior mesenteric vein (IMV) in vitro to identify ganglionic ne
28 erior mesenteric vein (SMV), in 37; inferior mesenteric vein (IMV), in 35; posterior superior pancrea
31 d the confluence of the splenic and superior mesenteric veins in 21 (60%) and 11 (31%) patients, resp
33 tomy, a second-order tributary branch of the mesenteric vein is cannulated to provide endovascular ac
36 rior vena cava (n = 10), portal and superior mesenteric veins (n = 7), splenic vein (n = 4), and aort
38 histosoma mansoni blood flukes reside in the mesenteric veins of their vertebrate hosts, where they a
40 ceptor 7/8 (TLR7/8)-mediated inflammation of mesenteric veins, platelet activation drives the rapid m
42 which can be prevented by normalizing portal-mesenteric vein (PMV) glycemia alone during the antecede
44 ctomy (PD) with en-bloc portal vein/superior mesenteric vein (PV/SMV) resection is used in patients w
45 infusion of lipopolysaccharide (LPS) into a mesenteric vein served as an acute, liver-focused model
46 llograft superior mesenteric artery-superior mesenteric vein (SMA-SMV) AVF in a pancreas-after-kidney
47 evaluated images for two new signs, superior mesenteric vein (SMV) "beaking" and "criss-cross" of the
48 mallest axes (r = -0.39), change in superior mesenteric vein (SMV) and/or portal vein (hereafter, SMV
49 to the liver and atypically located superior mesenteric vein (SMV) joining with the splenic vein to f
51 rojejunostomy line in two patients, superior mesenteric vein (SMV) thrombosis in two patients, and in
52 ed in 37; splenic vein (SV), in 37; superior mesenteric vein (SMV), in 37; inferior mesenteric vein (
53 y measurements were obtained in the superior mesenteric vein (SMV), splenic vein (SV), portal vein (P
55 ior mesenteric artery, portal vein, superior mesenteric vein, splenic vein, hepatic veins, and inferi
56 patient had stent migration to the superior mesenteric vein that was removed at the time of DSRS.
58 xpectation of posttransplant cure, extensive mesenteric vein thrombosis and intestinal infarction, to
59 DVICE 11: Treatment of incidental portal and mesenteric vein thrombosis depends on estimated impact o
60 ery thromboembolism, 25 (22%) had a superior mesenteric vein thrombosis, and 4 (3%) had superior mese
61 ptomatic deep vein thrombosis and portal and mesenteric vein thrombosis, but there are unresolved iss
63 study was to determine the effectiveness of mesenteric vein to left portal vein bypass operation (ML
64 ycemic detection shifts away from the portal-mesenteric vein to some other loci (e.g., the brain) whe
66 l vein stump was performed from the inferior mesenteric vein to the umbilical portion of the left por